Defining the possibilities: Is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?

  • Shirin Nafisi
  • , Sabyasachi Roy
  • , Robert Gish
  • , Richard Manch
  • , Anita Kohli

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)41-56
Number of pages16
JournalExpert Review of Anti-Infective Therapy
Volume14
Issue number1
DOIs
StatePublished - Jan 2 2016
Externally publishedYes

ASJC Scopus Subject Areas

  • Microbiology
  • Microbiology (medical)
  • Virology
  • Infectious Diseases

Keywords

  • (5-10): sofosbuvir
  • Directly acting antivirals
  • Duration
  • Genotype 1
  • Hepatitis C
  • IFN free regimens
  • NS5B inhibitor

Cite this